<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT02230943</url>
  </required_header>
  <id_info>
    <org_study_id>RISE</org_study_id>
    <nct_id>NCT02230943</nct_id>
  </id_info>
  <brief_title>Rheumatology Informatics System for Effectiveness</brief_title>
  <acronym>RISE</acronym>
  <official_title>American College of Rheumatology's Rheumatology Informatics System for Effectiveness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American College of Rheumatology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American College of Rheumatology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The RISE Registry is an enhanced version of the ACR's Rheumatology Clinical Registry (RCR)&#xD;
      and allows for a simplified entry process, while establishing a best-in-class resource to&#xD;
      manage your patient population and improve patient care.&#xD;
&#xD;
      RISE provides participants with an infrastructure for robust quality improvement activities&#xD;
      leading to improved patient outcomes, patient population management and quality reporting&#xD;
      related to rheumatic diseases and drug safety. RISE gives physicians and researchers the&#xD;
      information they need to optimize patient outcomes, meet reporting requirements, and make&#xD;
      discoveries that advance rheumatology.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RISE helps providers benchmark performances on key rheumatology clinical quality measures and&#xD;
      align with best practice standards. The RISE benchmarking tool allows providers to view the&#xD;
      details of their patient population against established rheumatology quality metrics. RISE&#xD;
      allows access to aggregate data from other participating sites so providers can view their&#xD;
      patient population in comparison to other RISE participants.&#xD;
&#xD;
      RISE is integrated into an electronic health records (EHR) system, bringing a single point of&#xD;
      entry into one solution for filing for quality-based incentive payments, avoiding penalties,&#xD;
      complying with reporting requirements and tracking caseloads for quality monitoring and&#xD;
      improvement initiatives. RISE collects the data needed to meet current federal reporting&#xD;
      requirements.&#xD;
&#xD;
      Participating in RISE helps push the field of rheumatology practice forward. RISE provides a&#xD;
      source of information on patient outcomes and quality care for rheumatology leading to new&#xD;
      discoveries, better understanding and a source of comparative effectiveness research.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Controlling High Blood Pressure</measure>
    <time_frame>one year</time_frame>
    <description>Percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (&lt;140/90mmHg) during the measurement period.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100000</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Osteoarthritis</condition>
  <condition>Gout</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 18 years of age and older with one of the following diagnoses: rheumatoid&#xD;
             arthritis, osteoarthritis, gout&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Melissa D Francisco</last_name>
    <phone>404-633-3777</phone>
    <phone_ext>102</phone_ext>
    <email>mfrancisco@rheumatology.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rachel Myslinski, MBA</last_name>
    <phone>404-633-3777</phone>
    <phone_ext>824</phone_ext>
    <email>rmyslinski@rheumatology.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>American College of Rheumatology</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30319</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa D. Francisco</last_name>
      <phone>404-633-3777</phone>
      <phone_ext>102</phone_ext>
      <email>mfrancisco@rheumatology.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <study_first_submitted>August 29, 2014</study_first_submitted>
  <study_first_submitted_qc>August 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2014</study_first_posted>
  <last_update_submitted>August 29, 2014</last_update_submitted>
  <last_update_submitted_qc>August 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rheumatoid</keyword>
  <keyword>arthritis</keyword>
  <keyword>osteoarthritis</keyword>
  <keyword>gout</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT02230943
org study id: RISE
nct id: NCT02230943
lead sponsor: 
has dmc: No
The RISE Registry is an enhanced version of the ACR's Rheumatology Clinical Registry (RCR)
      and allows for a simplified entry process, while establishing a best-in-class resource to
      manage your patient population and improve patient care.

      RISE provides participants with an infrastructure for robust quality improvement activities
      leading to improved patient outcomes, patient population management and quality reporting
      related to rheumatic diseases and drug safety. RISE gives physicians and researchers the
      information they need to optimize patient outcomes, meet reporting requirements, and make
      discoveries that advance rheumatology.
RISE helps providers benchmark performances on key rheumatology clinical quality measures and
      align with best practice standards. The RISE benchmarking tool allows providers to view the
      details of their patient population against established rheumatology quality metrics. RISE
      allows access to aggregate data from other participating sites so providers can view their
      patient population in comparison to other RISE participants.

      RISE is integrated into an electronic health records (EHR) system, bringing a single point of
      entry into one solution for filing for quality-based incentive payments, avoiding penalties,
      complying with reporting requirements and tracking caseloads for quality monitoring and
      improvement initiatives. RISE collects the data needed to meet current federal reporting
      requirements.

      Participating in RISE helps push the field of rheumatology practice forward. RISE provides a
      source of information on patient outcomes and quality care for rheumatology leading to new
      discoveries, better understanding and a source of comparative effectiveness research.
observational model: Cohort
time perspective: Prospective
measure: Controlling High Blood Pressure
time frame: one year
description: Percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90mmHg) during the measurement period.
study pop: 
sampling method: Probability Sample
criteria: 
gender: All
minimum age: 18 Years
maximum age: N/A
healthy volunteers: Accepts Healthy Volunteers
last name: Melissa D Francisco
phone: 404-633-3777
phone ext: 102
email: mfrancisco@rheumatology.org
last name: Rachel Myslinski, MBA
phone: 404-633-3777
phone ext: 824
email: rmyslinski@rheumatology.org
facility: 
status: Recruiting
contact: 
country: United States
responsible party type: Sponsor
mesh term: Arthritis
mesh term: Osteoarthritis